“With populations exceeding 33 million people in Canada and over 830 million people throughout Europe, the combined size of the pain market in these countries potentially exceeds that of the United States,” explained Rik J Deitsch, Chairman and CEO of Nutra Pharma. “As we move forward with the registration process in Canada and Europe, we also plan to continue seeking qualified licensing partners to market and distribute our pain reliever worldwide,”
I don't see it as likely. Maybe a possibility based on the above paragraph.